In Vitro Phototoxicity Assay: A PDT-based Method to Evaluate the Phototoxic Potential of a Photosensitizer in Lung Cancer Cells
JoVE Encyclopedia of Experiments
Cancer Research
0 views • 5:08 min • April 30th, 2023
- Photodynamic therapy or PDT is a type of light therapy utilizing photosensitizers-- molecules activated by lights of specific wavelengths. An excited photosensitizer converts molecular oxygen present in cells to reactive oxygen species that cause cell death. To begin the assay, prepare a desired nanoparticle-based drug delivery system carrying the appropriate concentration of the photosensitizer, alone or in combination with a test drug.
Add the preferred concentration of this nanoparticle suspension into a culture of lung cancer cells. Incubate the culture in the dark for an appropriate time to facilitate cellular uptake of nanoparticles. Replace the suspension with the desired culture medium. Subsequently, position a photodynamic therapy fiber laser above the culture at an optimal distance facilitating uniform illumination. Irradiate the cells at an appropriate wavelength for the desired time and incubate overnight.
Replace the media with a suitable cytotoxicity measuring solution. Use a microplate reader to measure cell viability and quantify cytotoxic effects of the experimental treatment. Irradiated cells containing the photosensitizer show decreased viability. In the following protocol, we will perform an in vitro phototoxicity analysis of hypocrellin B, a photosensitizer, and paclitaxel, an anticancer drug, encapsulated in hyaluronic acid-ceramide nanoparticles in A549 lung cancer cells.
- To begin, synthesize hyaluronic acid-ceramide as described in the accompanying text protocol. Purify the product using a 3.5 kilodalton dialysis membrane and lyophilize it.
Next, prepare hyaluronic acid-ceramide nanoparticles by themselves, hyaluronic acid-ceramide nanoparticles along with the photosensitizer, and hyaluronic acid-ceramide nanoparticles with an anticancer agent and the photosensitizer.
Seed the lung cancer cell line A549 into the wells of a 24-well cell culture plate at a density of 1 times 10 to the fifth cells per well, and incubate the cells for 24 hours. The next day, remove the medium and wash the cells with 1 milliliter of PBS.
Then dissolve the prepared nanoparticles in PBS to a final concentration of 2 micromoles per milliliter of the photosensitizer, hypocrellin B, by vortexing.
Into four wells each, add 1 milliliter of PBS, 1 milliliter of the empty hyaluronic acid-ceramide nanoparticles, 1 milliliter of the nanoparticles containing the photosensitizer, and 1 milliliter of the nanoparticles containing both the photosensitizer and the anticancer drug.
When finished, cover the plate and incubate it at 37 degrees Celsius for four hours in the dark to allow for nanoparticle uptake into the cells. Then remove all of the solutions and wash the cells by adding 1 milliliter of cold PBS.
Repeat the washing step once more, and then add fresh culture medium. Next, place the 24-well culture plate under a photodynamic therapy fiber and position the fiber 1 centimeter from the first well.
- The distance from the photodynamic therapy fiber to the cells was the critical factor in this study. It was important to find out the optimal distance which can cover the whole cell with the light.
- Then put on safety glasses and turn out the lights. Illuminate the cells with the laser in the dark for between 5 and 40 seconds to activate highly reactive singlet oxygen and other free radicals in the photosensitizer-containing nanoparticles.
Following light exposure, incubate the cells in the dark for 24 hours. Next, aspirate the culture medium and wash the cells with 1 milliliter of cold PBS. Repeat the wash step once more and then add 100 microliters of media and 10 microliters of cytotoxicity measuring solution to each well.
Incubate cells in the solution for two hours in the dark and then move all the samples to a 96-well plate. Measure the absorbance at 450 nanometers using a microplate reader.
Overview
This study investigates the use of photodynamic therapy (PDT) in lung cancer cells using hypocrellin B as a photosensitizer. The protocol outlines the preparation of hyaluronic acid-ceramide nanoparticles for drug delivery and the subsequent analysis of cytotoxic effects on A549 lung cancer cells.
Key Study Components
Area of Science
- Photodynamic therapy
- Cancer treatment
- Nanoparticle drug delivery
Background
- Photodynamic therapy utilizes light-activated photosensitizers.
- Reactive oxygen species generated can induce cell death.
- Hyaluronic acid-ceramide nanoparticles can enhance drug delivery.
- A549 lung cancer cells are a common model for cancer research.
Purpose of Study
- To evaluate the cytotoxic effects of hypocrellin B and paclitaxel in lung cancer cells.
- To optimize the distance of laser illumination for effective PDT.
- To assess the viability of cancer cells post-treatment.
Methods Used
- Synthesis and purification of hyaluronic acid-ceramide nanoparticles.
- Preparation of nanoparticle formulations with photosensitizers and anticancer drugs.
- Incubation of A549 cells with nanoparticle suspensions.
- Laser irradiation to activate the photosensitizer and subsequent viability assessment.
Main Results
- Cells treated with photosensitizer showed decreased viability.
- Optimal laser distance was critical for effective PDT.
- Combination treatments demonstrated varying levels of cytotoxicity.
- Microplate reader analysis confirmed the cytotoxic effects of treatments.
Conclusions
- PDT using hypocrellin B is effective in reducing lung cancer cell viability.
- Nanoparticle delivery systems can enhance treatment efficacy.
- Further optimization of treatment parameters is necessary for clinical applications.
Frequently Asked Questions
Executive Industry Relevance
This protocol provides a standardized in vitro phototoxicity assay to evaluate photosensitizer efficacy in lung cancer models, supporting early target validation and mechanistic de-risking in PDT-based therapeutic development. By quantifying cytotoxic effects through controlled light exposure and viability readouts, the method enables predictive confidence in lead compound screening and portfolio triage for oncology pipelines.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Interrogates therapeutic hypothesis by linking photosensitizer activation to reactive oxygen species generation and cell death in lung cancer cells.
- Operational Value: Enables functional target validation through dose-dependent viability measurements following standardized PDT protocols.
- Predictive Value: Supports mechanistic de-risking by establishing causal relationships between light dose, photosensitizer concentration, and cytotoxic output.
Screening & Assay Development
- Assay Readiness: Prepares validated nanoparticle-photosensitizer systems for reproducible compound screening in lung cancer models.
- Quantitative Output: Generates dose-response viability data via microplate reader absorbance measurements at 450 nm for comparative compound evaluation.
- Platform Reuse: Establishes a scalable PDT-based assay framework adaptable to other photosensitizers, drugs, and cell lines for downstream screening campaigns.
Translational & Preclinical Research
- Disease Relevance: Uses A549 lung cancer cells as a translational model to assess photosensitizer performance in a clinically relevant context.
- Preclinical Continuity: Bridges discovery-stage PDT optimization with preclinical validation by defining critical parameters such as laser distance and incubation time.
- Risk-Adjusted Advancement: Informs go/no-go decisions by quantifying phototoxic potential and combination therapy effects prior to in vivo studies.
Pipeline & Workflow Integration
The assay fits within the discovery-to-preclinical continuum, enabling hypothesis testing in early discovery, assay standardization in screening, and parameter optimization for translational relevance.
- Discovery Biology: Supports pathway clarification by measuring cytotoxic effects of photosensitizer-drug combinations under controlled light activation.
- Screening: Delivers reproducible, quantitative viability readouts that facilitate compound comparison and hit selection in PDT-focused campaigns.
- Analytics: Provides standardized cytotoxicity measurements via microplate reader, enabling statistical comparison of treatment groups.
- Translational Research: Connects nanoparticle delivery efficiency to phototoxic outcome, supporting biomarker-aligned advancement decisions.
- Enterprise Reuse: Defines a modular PDT assay platform applicable across photosensitizer libraries and cancer models for sustained R&D value.
Operational & Enterprise Impact
- Scientific Value: Delivers mechanistic insight into photosensitizer activation and cell death pathways, reducing ambiguity in target validation.
- Operational Value: Ensures assay reproducibility through standardized light exposure, incubation timing, and viability quantification.
- Strategic Value: Improves capital efficiency by enabling early de-risking of PDT candidates before costly in vivo studies.
- Portfolio Impact: Supports risk-adjusted prioritization of photosensitizer-drug combinations based on quantifiable cytotoxic efficacy.
Implementation Considerations
- Requires expertise in photodynamic therapy, nanoparticle formulation, and cell culture techniques.
- Dependent on access to tunable fiber laser systems and microplate readers for precise light delivery and absorbance measurement.
- Necessitates cross-team standardization of light distance, exposure duration, and dark incubation periods to ensure data comparability.
- Involves adaptation considerations when transferring the assay to different photosensitizers, drugs, or cell lines beyond A549 and hypocrellin B.
- Practical limitations include the need for dark handling during nanoparticle uptake and post-irradiation phases to prevent premature photosensitizer activation.
Biopharma FAQs
Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro
Related Videos
0 Views
Selective Cell Elimination from Mixed 3D Culture Using a Near Infrared Photoimmunotherapy Technique
Related Videos
0 Views
An In Vitro Approach to Photodynamic Therapy
Related Videos
0 Views
In Vivo Antitumor Efficacy Analysis of PDT: A Technique to Determine the Phototoxic Potential of a Photosensitizer in Tumor Bearing Mice
Related Videos
0 Views
Photodynamic Therapy with Blended Conducting Polymer/Fullerene Nanoparticle Photosensitizers
Related Videos
0 Views
Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Related Videos
0 Views
Assessment of the Cytotoxic and Immunomodulatory Effects of Substances in Human Precision-cut Lung Slices
Related Videos
0 Views
An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model
Related Videos
0 Views
In Vitro and In Vivo Evaluation of Photocontrolled Biologically Active Compounds - Potential Drug Candidates for Cancer Photopharmacology
Related Videos
0 Views
LED-Based In Vitro Screening for Assessing Photoactivable Molecules in Bacterial Photodynamic Inactivation
Related Videos
0 Views
Last updated: 29 August 2026